These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 24556419

  • 21. Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice.
    Ragelle H, Crauste-Manciet S, Seguin J, Brossard D, Scherman D, Arnaud P, Chabot GG.
    Int J Pharm; 2012 May 10; 427(2):452-9. PubMed ID: 22387278
    [Abstract] [Full Text] [Related]

  • 22. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
    Wu XL, Kim JH, Koo H, Bae SM, Shin H, Kim MS, Lee BH, Park RW, Kim IS, Choi K, Kwon IC, Kim K, Lee DS.
    Bioconjug Chem; 2010 Feb 17; 21(2):208-13. PubMed ID: 20073455
    [Abstract] [Full Text] [Related]

  • 23. Cationic nanoemulsion as a delivery system for oligonucleotides targeting malarial topoisomerase II.
    Bruxel F, Cojean S, Bochot A, Teixeira H, Bories C, Loiseau PM, Fattal E.
    Int J Pharm; 2011 Sep 20; 416(2):402-9. PubMed ID: 21291974
    [Abstract] [Full Text] [Related]

  • 24. Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery.
    Hossen MN, Kajimoto K, Akita H, Hyodo M, Harashima H.
    J Control Release; 2012 Oct 28; 163(2):101-10. PubMed ID: 22982237
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA.
    Toxic Rep Ser; 1999 Aug 28; (59):1-66, A1-E7. PubMed ID: 11803702
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
    de Wolf HK, Snel CJ, Verbaan FJ, Schiffelers RM, Hennink WE, Storm G.
    Int J Pharm; 2007 Mar 01; 331(2):167-75. PubMed ID: 17134859
    [Abstract] [Full Text] [Related]

  • 36. Multivesicular liposome (MVL) sustained delivery of a novel synthetic cationic GnRH antagonist for prostate cancer treatment.
    Wang T, Gao L, Quan D.
    J Pharm Pharmacol; 2011 Jul 01; 63(7):904-10. PubMed ID: 21635255
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.
    Abu Lila AS, Kizuki S, Doi Y, Suzuki T, Ishida T, Kiwada H.
    J Control Release; 2009 Jul 01; 137(1):8-14. PubMed ID: 19285528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.